US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 28, 2021 (5 years ago)

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications

What was recalled

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

Recalling firm
Teva Pharmaceuticals USA
NDC code
0591-3508-04
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0235-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clonidine recalls

See all